Gene: RNF39
Official Full Name: ring finger protein 39provided by HGNC
Gene Summary: This gene lies within the major histocompatibility complex class I region on chromosome 6. Studies of a similar rat protein suggest that this gene encodes a protein that plays a role in an early phase of synaptic plasticity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01553 | RNF39 Knockout cell line (HCT 116) | Human | RNF39 | 1:2~1:4 | Negative | Online Inquiry |
KO01554 | RNF39 Knockout cell line (HEK293) | Human | RNF39 | 1:3~1:6 | Negative | Online Inquiry |
RNF39 Gene Knockout Cell Lines are engineered cellular models that lack the expression of the RNF39 gene, a critical component in various cellular processes including protein ubiquitination and signal transduction pathways. These knockout cell lines are developed using cutting-edge CRISPR-Cas9 gene editing technologies, ensuring precise deletion of the RNF39 gene to facilitate comprehensive functional studies of gene loss and related phenotypes.
The primary function of RNF39 is to act as an E3 ubiquitin ligase, which plays a pivotal role in regulating protein degradation, cellular stress responses, and signal transduction, particularly in the context of cancer biology and cellular homeostasis. By utilizing RNF39 knockout cell lines, researchers can investigate the downstream effects of RNF39 deficiency on cellular pathways, thereby expanding our understanding of the gene's role in diseases. These cell lines provide an invaluable tool for elucidating the molecular mechanisms underlying tumor progression and response to therapeutic interventions.
Scientifically, RNF39 knockout cell lines are indispensable in both research and clinical contexts. Their use spans areas such as cancer research, drug discovery, and gene therapy, providing insights into the potential therapeutic targeting of the ubiquitin-proteasome system. Compared to alternative models, these knockout cell lines offer a more controlled and precise approach to studying gene function and regulation, thus enhancing the validity of experimental results.
The advantages of RNF39 knockout cell lines include their ability to offer reproducible results, authentic biological relevance, and ease of integration into existing research workflows. For researchers and clinicians focused on unraveling the complexities of gene function and disease mechanisms, these cell lines represent a significant advancement in both in vitro experimental designs and translational applications.
As specialists in the development of innovative biological tools, our company is committed to providing high-quality research products that enable scientists to push the boundaries of discovery in gene function and regulation. Our RNF39 Gene Knockout Cell Lines are a testament to our dedication to scientific excellence and the advancement of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.